These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24498403)

  • 1. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
    PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
    Zhang F; Yang Y; Guo C; Wang Y
    Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk.
    Du H; Song GX; Fang MZ; Shu YQ; Zhao X; Zhu LJ
    J Biomed Res; 2019 Jun; 33(3):173-180. PubMed ID: 30057371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
    Li Z; Wang J; Wang F; Ma Z; Yu Z
    Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
    de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
    J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.
    Zhang CD; Li HT; Liu K; Lin ZD; Peng QL; Qin X; He M; Wu H; Mo ZN; Yang XL
    Asian Pac J Cancer Prev; 2014; 15(18):7713-8. PubMed ID: 25292051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer.
    Wu Z; Li Y; Li S; Zhu L; Li G; Yu Z; Zhao X; Ge J; Cui B; Dong X; Tian S; Hu F; Zhao Y
    Med Oncol; 2013; 30(3):565. PubMed ID: 23715747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
    Ji GH; Li M; Cui Y; Wang JF
    Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
    Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
    Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
    Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
    Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
    Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
    Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
    Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
    Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.
    Theodoropoulos GE; Gazouli M; Vaiopoulou A; Leandrou M; Nikouli S; Vassou E; Kouraklis G; Nikiteas N
    Int J Colorectal Dis; 2011 Sep; 26(9):1113-8. PubMed ID: 21538054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
    Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
    Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CASP-8 -652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis.
    Chen D; Ma T; Liu XW; Liu Z
    Exp Ther Med; 2012 Oct; 4(4):762-770. PubMed ID: 23170140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
    Chatterjee K; Williamson AL; Hoffman M; Dandara C
    J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Cai J; Ye Q; Luo S; Zhuang Z; He K; Zhuo ZJ; Wan X; Cheng J
    Oncotarget; 2017 Aug; 8(34):56780-56790. PubMed ID: 28915630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.